P3818Association between e-cigarette use and myocardial infarction: analysis of two large population-representative studies in USA

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
K Farsalinos ◽  
V Voudris ◽  
R Niaura

Abstract Background Smoking is a major risk factor for cardiovascular disease. E-cigarettes are an emerging and controversial public health issue. It is unknown how e-cigarette use affects cardiovascular disease. Purpose In this study, we examine the association between e-cigarette use and myocardial infarction (MI) in two large population-representative studies in USA. Methods The study analyzed the 2016 and 2017 (pooled) National Health Interview Survey (NHIS, N=59,770) and the 2017 Behavioral Risk Factor Surveillance System survey (BRFSS, N=450,016). Proportions (95% CI) were calculated and logistic regression analyses were performed to identify the association between e-cigarette use and MI. Independent variables in the models were demographics, e-cigarette use (daily, some days, former, never), smoking status (daily, some days, former, never) and risk factors for MI (hyperlipidemia, hypertension, diabetes, BMI). Exercise was also introduced as an independent variable, where available (BRFSS only). Results In NHIS, 90.9% (88.8–93.0%) of daily e-cigarette users were current or former smokers. The respective proportion in BRFSS was 86.3% (85.3–87.3%). The majority of some days and former e-cigarette users (≥70%) were also current or former smokers in both surveys. MI was reported by 4.2% (2.7–5.7%) of daily vs. 3.2% (3.0–3.4%) of never e-cigarette users in NHIS (P=NS), and 4.2% (3.5–6.1%) vs. 4.4% (4.2–4.5%) in BRFSS (P=NS), respectively. In NHIS, daily e-cigarette use was not associated with MI (OR: 1.59, 95% CI: 0.97–2.61, P=0.067). Some days and former e-cigarette use were also not associated with MI. In the BRFSS, daily e-cigarette use was not associated with MI (OR: 1.40, 95% CI: 0.96–2.04, P=0.077), but some days (OR: 1.51, 95% CI: 1.09–2.11, P=0.014) and former e-cigarette use (OR: 1.14, 95% CI: 1.02–1.28, P=0.021) were associated with MI. In both surveys, all patterns of smoking (daily, some days and former smoking) and established risk factors (hypertension, hyperlipidemia, diabetes) were consistently and strongly associated with MI. ORs for MI Conclusion E-cigarettes are predominantly used by current and former smokers. Daily e-cigarette use was not associated with having had an MI, while inconsistent and seemingly paradoxical associations are observed for some days and former e-cigarette use. Long-term epidemiological studies are needed to examine how e-cigarette use affects the risk of MI, considering the complex interactions between smoking and e-cigarette use. Acknowledgement/Funding None

2009 ◽  
Vol 35 (5) ◽  
pp. 770-777 ◽  
Author(s):  
Kyeongra Yang ◽  
Eileen R. Chasens ◽  
Susan M. Sereika ◽  
Lora E. Burke

Purpose The purpose of this study was to examine the association between cardiovascular risk factors and the presence of diabetes in a large population-level dataset. Methods A secondary analysis was conducted using data from the 2007 Behavioral Risk Factor Surveillance System, a population-based survey (n = 403,137) conducted in the United States. Results The majority of the respondents were middle-aged and overweight. Approximately half of the sample reported little or no physical activity. Estimates from a logistic regression model for a weighted sample of white, black, and Hispanic adults revealed that having hypertension or elevated cholesterol was a strong predictor of diabetes even when controlling for age, gender, race, education, income, body mass index, smoking status, and physical activity. Conclusions The results confirmed the importance of diabetes educators counseling patients with hypertension or hypercholesterolemia about their increased risk for developing diabetes.


2013 ◽  
Vol 26 (5) ◽  
pp. 601
Author(s):  
Tiago Torres ◽  
Rita Sales ◽  
Carlos Vasconcelos ◽  
Manuela Selores

Psoriasis is a common, chronic and systemic inflammatory disease associated with several comorbidities, such as obesity, hypertension, diabetes, dyslipidaemia and metabolic syndrome, but also with an increased risk of cardiovascular disease, like myocardial infarction or stroke. The chronic inflammatory nature of psoriasis has been suggested to be a contributing and potentially independent risk factor for the development of cardiovascular comorbidities and precocious atherosclerosis. Aiming at alerting clinicians to the need of screening and monitoring cardiovascular diseases and its risk factors in psoriatic patients, this review will focus on the range of cardiometabolic comorbidities and increased risk of cardiovascular disease associated with psoriasis.


PLoS ONE ◽  
2021 ◽  
Vol 16 (2) ◽  
pp. e0247105
Author(s):  
Dieu-My T. Tran ◽  
Nirmala Lekhak ◽  
Karen Gutierrez ◽  
Sheniz Moonie

ObjectiveCardiovascular disease (CVD) remains the number one cause of death in the US and Nevada is ranked 11th highest for CVD mortality. The study sought to examine the association between self-reported risk factors and CVD presence among adult Nevadans, between years 2011 and 2017.MethodsThis is a cross-sectional, population-based study that utilized the 2011 and 2017 Nevada Behavioral Risk Factor Surveillance System data. Data were analyzed between 2019 and 2020.ResultsA total of 5,493 and 3,764 subjects in 2011 and 2017, respectively were included. BMI (overweight/obesity) remained the most prevalent CVD risk factor. The second most common CVD risk factor was high cholesterol, followed by hypertension. Compared to females, males were 1.64 times more likely to have reported CVD in 2011, which increased to 1.92 in 2017. Compared to non-smokers, everyday smokers were 1.96 times more likely in 2011 and 3.62 times more likely in 2017. Individuals with high cholesterol status were 2.67 times more likely to have reported CVD compared to those with normal levels in 2011. In 2011, individuals with hypertension were 3.74 times more likely to have reported CVD compared to those who did not have hypertension. This relationship increased its magnitude of risk to 6.18 times more likely in 2017. In 2011, individuals with diabetes were 2.90 times more likely to have reported CVD compared to those without the condition.ConclusionsPublic health and healthcare providers need to target preventable cardiovascular risk factors and develop recommendations and strategies locally, nationally, and globally.


2019 ◽  
Vol 81 (3) ◽  
Author(s):  
Nurliyana Juhan ◽  
Zarina Mohd Khalid ◽  
Yong Zulina Zubairi ◽  
Ahmad Syadi Mahmood Zuhdi ◽  
Wan Azman Wan Ahmad

Cardiovascular disease is the leading cause of death in Malaysia and globally. This study aimed to identify associated risk factors in cardiovascular disease among ST elevation myocardial infarction (STEMI) male patients and obtain a feasible model to describe the data. A total of 16,673 STEMI male patients from 18 participating hospitals across Malaysia in the National Cardiovascular Disease Database-Acute Coronary Syndrome (NCVD-ACS) registry year 2006-2013 were analysed. Univariate analysis was conducted. Significant variables from the univariate analysis were further analysed by a multivariate logistic analysis to identify the prognostic factors. The most prevalent risk factor for male patients was smoking (79.3%), followed by hypertension (54.9%) and diabetes mellitus (40.4%). At univariate level, this study is consistent with the findings from the Malaysian National Health and Morbidity Survey (NHMS) where smoking is a significant risk factor. After adjustment in multivariate logistic model, the risk factors for cardiovascular death among male patients are related to age, premorbid condition such as diabetes mellitus, hypertension, family history of CVD, Killip class, type of treatment such as percutaneous coronary intervention (PCI) and relevant comorbidity such as renal disease. Drastic efforts in the management of all risk factors in males is needed to improve adherence outcomes.


Author(s):  
Niki Kusuma Bangsa ◽  
Rochmad Romdoni ◽  
Subagyo Subagyo

Introduction: Heart failure (HF) has emerged as a cardiovascular disease with high prevalence in developing countries. The highest number was expected to increase over the next few decades. Moreover, most people with HF do not show specific symptoms earlier, thus death often occurs. This study was undertaken to give an insight into the clinical symptoms and risk factors of HF.Methods: This cross-sectional study utilized medical records from Dr. Soetomo General Hospital between 6 months (July-December 2016). Eligibility criteria included female patients diagnosed with HF at the hospital with a classification of NYHA I-IV. Risk factors data from the participants such as hypertension, diabetes mellitus, dyslipidemia, body mass index (BMI), smoking status, and history of cardiovascular disease were collected. Clinical symptoms were reported descriptively.Results: From 84 patients admitted with HF in the hospital from July until December 2016, 53 were males (63.1%). In all groups, hypertension (35.6%) was the highest prevalence risk factor, followed by diabetes mellitus (25.3%), and a history of cardiovascular disease (17.2%). In this study, the most common symptom was shortness of breathing, contributing to 72.6%, followed by chest pain (10.7%), and body weakness (6%).Conclusion: This study concluded that most of the respondents were male, aged 46-65 years old. The highest risk factor that contribute to an HF was hypertension. The most common symptom in patients with HF in the hospital was shortness of breathing. Studies further emphasize the need for primordial prevention related to symptoms and risk factors of HF. 


Sign in / Sign up

Export Citation Format

Share Document